These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 2206941

  • 21. The advantageous use of hypoxic tumour cells in cancer therapy: identical chemosensitization by metronidazole and misonidazole at moderately elevated temperatures.
    Urano M, Wong KH, Reynolds R, Begley J.
    Int J Hyperthermia; 1995; 11(3):379-88. PubMed ID: 7636324
    [Abstract] [Full Text] [Related]

  • 22. Enhancement of the action of alkylating agents by single high, or chronic low doses of misonidazole.
    McNally NJ, Hinchliffe M, de Ronde J.
    Br J Cancer; 1983 Aug; 48(2):271-8. PubMed ID: 6882665
    [Abstract] [Full Text] [Related]

  • 23. Effects of oxygenation and pH on tumor cell response to alkylating chemotherapy.
    Siemann DW, Chapman M, Beikirch A.
    Int J Radiat Oncol Biol Phys; 1991 Feb; 20(2):287-9. PubMed ID: 1991690
    [Abstract] [Full Text] [Related]

  • 24. Misonidazole and CCNU: further evidence for a pharmacokinetic mechanism of chemosensitization and therapeutic gain.
    Lee FY, Workman P.
    Br J Cancer; 1984 May; 49(5):579-85. PubMed ID: 6722006
    [Abstract] [Full Text] [Related]

  • 25. Enhanced tumor responses through therapies combining CCNU, MISO and radiation.
    Siemann DW, Hill SA.
    Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1623-6. PubMed ID: 6480451
    [Abstract] [Full Text] [Related]

  • 26. Effect of clinical levels of misonidazole on the response of tumour and normal tissues in the mouse to alkylating agents.
    Brown JM, Hirst DG.
    Br J Cancer; 1982 May; 45(5):700-8. PubMed ID: 7082556
    [Abstract] [Full Text] [Related]

  • 27. Manipulation of oxygenation in a human tumour xenograft with BW12C or hydralazine: effects on responses to radiation and to the bioreductive cytotoxicity of misonidazole or RSU-1069.
    Cole S, Robbins L.
    Radiother Oncol; 1989 Nov; 16(3):235-43. PubMed ID: 2587812
    [Abstract] [Full Text] [Related]

  • 28. Enhancing effect of misonidazole on the response of the RIF-1 tumour to cyclophosphamide.
    Law MP, Hirst DG, Brown JM.
    Br J Cancer; 1981 Aug; 44(2):208-18. PubMed ID: 7272187
    [Abstract] [Full Text] [Related]

  • 29. Effect of pretreatment with phenobarbital or SKF 525A on the toxicity and antitumor activity of lomustine.
    Siemann DW.
    Cancer Treat Rep; 1983 Mar; 67(3):259-65. PubMed ID: 6831472
    [Abstract] [Full Text] [Related]

  • 30. The effect in the KHT sarcoma of CCNU and MISO on cell cycle progression evaluated by flow-cytometry.
    Hill SA, Bauer KD, Keng PC, Siemann DW.
    Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1619-22. PubMed ID: 6480450
    [Abstract] [Full Text] [Related]

  • 31. Chemosensitization of mouse tumors by misonidazole.
    Randhawa VS, Stewart FA, Denekamp J.
    Int J Radiat Oncol Biol Phys; 1982 Sep; 8(3-4):671-4. PubMed ID: 7107397
    [Abstract] [Full Text] [Related]

  • 32. Enhancement of CCNU cytotoxicity by misonidazole: possible therapeutic gain.
    Hirst DG, Brown JM, Hazlehurst JL.
    Br J Cancer; 1982 Jul; 46(1):109-16. PubMed ID: 7201845
    [Abstract] [Full Text] [Related]

  • 33. Postirradiation modification of tumor blood flow: a method to increase the effectiveness of chemical radiosensitizers.
    Chaplin DJ.
    Radiat Res; 1988 Aug; 115(2):292-302. PubMed ID: 3406369
    [Abstract] [Full Text] [Related]

  • 34. Enhancement of melphalan-induced tumour cell killing by misonidazole: an interaction of competing mechanisms.
    Horsman MR, Evans JW, Brown JM.
    Br J Cancer; 1984 Sep; 50(3):305-16. PubMed ID: 6466544
    [Abstract] [Full Text] [Related]

  • 35. Misonidazole-induced chemopotentiation of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea toxicity in O6-methylguanine-DNA methyltransferase proficient (Mer+) and deficient (Mer-) cell lines.
    Mulcahy RT.
    Cancer Res; 1986 Jun; 46(6):2892-7. PubMed ID: 3698015
    [Abstract] [Full Text] [Related]

  • 36. Chemosensitization by misonidazole in CCNU-treated spheroids and tumours.
    Durand RE, Chaplin DJ.
    Br J Cancer; 1987 Aug; 56(2):103-9. PubMed ID: 3663461
    [Abstract] [Full Text] [Related]

  • 37. Radiation sensitization and chemopotentiation: RSU 1069, a compound more efficient than misonidazole in vitro and in vivo.
    Adams GE, Ahmed I, Sheldon PW, Stratford IJ.
    Br J Cancer; 1984 May; 49(5):571-7. PubMed ID: 6547051
    [Abstract] [Full Text] [Related]

  • 38. Hydralazine-induced tumor hypoxia: a potential target for cancer chemotherapy.
    Chaplin DJ.
    J Natl Cancer Inst; 1989 Apr 19; 81(8):618-22. PubMed ID: 2704051
    [Abstract] [Full Text] [Related]

  • 39. Enhancement of the anti-tumor effect of melphalan in experimental mice by some vaso-active agents.
    Adams GE, Stratford IJ, Godden J, Howells N.
    Int J Radiat Oncol Biol Phys; 1989 May 19; 16(5):1137-9. PubMed ID: 2715059
    [Abstract] [Full Text] [Related]

  • 40. 2-Nitroimidazole potentiation of nitrosourea induced cytotoxicity in subcutaneous implants of rat 9L brain tumor cells.
    Wong KH, Wallen CA, Wheeler KT.
    J Neurooncol; 1991 Aug 19; 11(1):17-25. PubMed ID: 1833513
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.